OMICS Technologies For Predictive Modeling of Infectious Diseases Program

by: Michael Saunders

The National Institute of Health, more commonly referred to as NIH, is a federal government agency operating within the United States Department of Health and Human Services that is primarily responsible for supporting the country's biomedical and health-related research studies.

The grants and initiatives of the NIH are all geared towards the successful realization of its primary agency mission which is to "seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability."

In keeping with this mission, the National Institutes of Health has formed a partnership with the National Institute of Allergy and Infectious Diseases (NIAID) in an attempt to establish the OMICS Technologies For Predictive Modeling of Infectious Diseases Program.

The program is specifically designed to aid in the development and validation of predictive models of infectious disease initiation, progression and outcomes while employing integrated datasets generated from a combination of "omics" technologies.

OMICS technologies refer to the process involving rapid and accurate measurements tens and hundreds of thousands of data points (i.e., DNA sequences, gene expression levels) in a short period of time.

At present, there four major types of "omics" technologies that are being used to gather data, these include genomics, transcriptomics, proteomics, metabolomics.

  (continued...)

OMICS Technologies For Predictive Modeling of Infectious Diseases Program
  Page 2

About The Author Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. He also maintains Websites providing resources on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Competitive Revision for Technology Development Within Biomedical Technology Research Centers Program
The National Institutes of Health has formed a partnership with the National Center for Research Resources (NCRR) in an attempt to establish the Competitive Revision for Technology Development Within Biomedical Technology Research Centers Program.

---

Money Follows the Person Rebalancing Grant Demonstration Program
The Centers for Medicare & Medicaid Services has recently established the Money Follows the Person Rebalancing Grant Demonstration Program wherein they aim to assist the states to balance their long-term care systems and help Medicaid enrollees transition from institutions to communities.

---

Early-Stage Innovative Technology Development for Cancer Research Program
The National Institutes of Health has collaborated with the National Cancer Institute(NCI) in order to establish Early-Stage Innovative Technology Development for Cancer Research Program, wherein both agencies intend to solicit grant applications expressing intents to conduct funded exploratory research projects that concentrate on the inception and development unique, innovative technological advances that could potentially be utilized in the study of cancer.

---

Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability Program
In this capacity, the Food and Drug Administration has recently established the Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability Program in an attempt to study the effects of various physicochemical properties of ophthalmic suspensions and emulsions on ocular bioavailability.

---